more_reports

The Latest Biotechnology / Pharmaceuticals Articles from Streetwise Reports

Is This Pharma Set To Break Out After COPD Drug Approval?

  ()
Clinical-stage biopharmaceutical company Verona Pharma Plc is looking toward a pivotal year as its new chronic obstructive pulmonary disease (COPD) drug ensifentrine nears possible approval by the FDA. At least two research companies have named it a top pick for 2024.

This Biotech Is a Potential Disruptor, Expert Says

Contributed Opinion
  ()
Chris Temple of The National Investor shares why he believes BetterLife Pharma Inc. is an Immediate Buy.

NY Biotech Has Potentially Game Changing Anxiety Therapy

Research Report
  ()
Mind Medicine (MindMed) Inc. recently announced positive results from its Phase 2b trial of MM120 in generalized anxiety disorder, according to a Roth MKM research note.

Alt-Pharma VC adds 7% Stake in Testing Strip Firm

  ()
Alt pharma is hot these days, and few companies are coming in hotter than Safe Supply Streaming Co. Ltd., which just secured a 7% stake in a leading medical test company to expand its functional portfolio.

Cash Rich Biotech Could Win a Lawsuit With Lilly, Expert Says

Contributed Opinion
  ()
Ron Struthers explains how the cash value of this biotech is about $1.68/share and the stock is selling at around -58% discount to cash value. He also discusses a recent lawsuit with Eli Lilly.

Drug Reformer Subsidiary Inspected for Dealer License

  ()
In a "transformative moment" for the company, a Safe Supply Streaming Co. Ltd. subsidiary has undergone an official inspection by Health Canada to acquire a dealer license to produce, distribute, and export controlled substances.

Leadership Cuts Won't Slow This Biotech

Research Report
  ()
While three executive officers have been cut from Kronos Bio Inc., it is still a Buy, according to an H.C. Wainwright & Co. report.

Pharma Co. Primed for Future Business

Research Report
  ()
Analysts at Research Capital believe that Knight Therapeutics Inc. is primed to conduct future business development.

Healthcare Co. Exceeds Expectations in Performance

Research Report
  ()
Sensus Healthcare Inc. released fourth-quarter financials that surpassed expectations, according to an H.C. Wainwright & Co. research note.

Showing Results: 26 to 34 of 34 Prev